ADAM17 and cancer: Similarly, the formation of 3‐dimensional spheroid aggregates was dramatically diminished in A549 cells either deficient in ADAM17 or treated with A17pro, suggesting that ADAM17 can also impact on the proliferative capacity of cancer stem (i.e., initiating) cells in LAC (Figs EV5G and 5H).